Looking for bargains in the sector best positioned to ride aging demographic trends? These five are screaming buys.
A collection of underperforming stocks held by Soros Fund Management that could be set to bounce strongly.
The generic-drug market is sizzling hot. Here are three investing ideas to catch some of that heat wave.
Let's see what the numbers say about Abbott (ABT).
Keep an eye on Amarin, Cubist, and Abaxis -- they could make big moves during today's trading.
A confluence of factors is killing off coal plants one by one.
Written off for dead in 2009, this drug may show increased efficacy at higher doses.
The Tony Awards of utilities have been announced.
Can this utility electrify your earnings?
The utility opts for regulation over generation.